Anti-thrombotic agents including UFH, LMWHs, DTIs, and warfarin have been reviewed and commissioned expansively for not only the treatment of thrombosis but also for preventive measures as well. Lately however, novel oral anticoagulants have surfaced from clinical development and are expected to replace the long-standing drugs in the upcoming years massively due to their easy management and more favourable pharmacodynamic attributes.